Skip to main content

Table 2 Predictors of progression free survival

From: Long-term survival rates of patients with nasopharyngeal carcinoma treated by radiochemotherapy: a retrospective cohort study

 

P value

Exp(B)

95.0% CI for Exp(B)

Lower

Upper

Age

.125

1.030

.992

1.069

Sex

.078

2.838

.890

9.050

T stage

 T1 (reference)

.270

   

 T2

.232

.475

.141

1.607

 T3

.054

.321

.101

1.018

 T4

.171

.395

.105

1.491

N stage

 N0 (reference)

.392

   

 N1

.111

4.489

.708

28.459

 N2

.189

3.071

.576

16.381

 N3

.119

3.597

.720

17.962

Induction ChTa

.312

.616

.241

1.577

Receiving Planned RT dose (70Gy)

.041

2.998

1.044

8.609

Receiving Planned ChT Cyclesb

.251

1.785

.663

4.805

Duration of RT

.121

.966

.926

1.009

  1. aChemotherapy
  2. bTwo 3-weekly or 6-weekly cisplatin